No single analytical technique tells the whole story of a bioconjugate. Learn how experts are integrating advanced separations and multi-detector technologies to unlock the critical quality attributes that drive successful development.
Peer Exchange
In this exclusive BioPharm International Peer Exchange video series, Chris Spivey, Director of Industry Relations and Strategic Partnerships, talks with industry experts about various aspects of Cell and Gene Therapies with a focus on reducing manufacturing bottlenecks by creating smaller automated footprint installations, better integrating analytics advances including harnessing artificial intelligence, and above all lowering barriers to access by lowering costs while improving timelines.
In this exclusive BioPharm International Peer Exchange video series, Chris Spivey, Director of Industry Relations and Strategic Partnerships, talks with industry experts about various aspects of mRNA scientific and commercial progress as it intersects with compliance and regulatory streamlining, potentially as a “platform” pathway.
Advertisement
Advertisement